These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review. Visentini M; Tinelli C; Colantuono S; Monti M; Ludovisi S; Gragnani L; Mitrevski M; Ranieri J; Fognani E; Piluso A; Granata M; De Silvestri A; Scotti V; Mondelli MU; Zignego AL; Fiorilli M; Casato M Autoimmun Rev; 2015 Oct; 14(10):889-96. PubMed ID: 26031898 [TBL] [Abstract][Full Text] [Related]
26. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand? Cacoub P; Delluc A; Saadoun D; Landau DA; Sene D Ann Rheum Dis; 2008 Mar; 67(3):283-7. PubMed ID: 17644544 [TBL] [Abstract][Full Text] [Related]
28. Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab. Baerlecken NT; Schmidt RE Clin Rheumatol; 2013 Mar; 32 Suppl 1():S19-20. PubMed ID: 20213127 [TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus-induced vasculitis: therapeutic options. Cacoub P; Terrier B; Saadoun D Ann Rheum Dis; 2014 Jan; 73(1):24-30. PubMed ID: 23921995 [TBL] [Abstract][Full Text] [Related]
30. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. Giuggioli D; Manfredi A; Colaci M; Manzini CU; Antonelli A; Ferri C Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565 [TBL] [Abstract][Full Text] [Related]
31. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis. Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850 [TBL] [Abstract][Full Text] [Related]
32. Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab. Koukoulaki M; Abeygunasekara SC; Smith KG; Jayne DR Nephrol Dial Transplant; 2005 Jan; 20(1):213-6. PubMed ID: 15632353 [No Abstract] [Full Text] [Related]
33. PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis. Saadoun D; Resche Rigon M; Pol S; Thibault V; Blanc F; Pialoux G; Karras A; Bazin-Kara D; Cazorla C; Vittecoq D; Musset L; Peltier J; Decaux O; Ziza JM; Lambotte O; Cacoub P J Hepatol; 2015 Jan; 62(1):24-30. PubMed ID: 25135864 [TBL] [Abstract][Full Text] [Related]
34. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Ferri C; Cacoub P; Mazzaro C; Roccatello D; Scaini P; Sebastiani M; Tavoni A; Zignego AL; De Vita S Autoimmun Rev; 2011 Nov; 11(1):48-55. PubMed ID: 21821153 [TBL] [Abstract][Full Text] [Related]
35. Cryoglobulinemia vasculitis: how to handle. Desbois AC; Comarmond C; Saadoun D; Cacoub P Curr Opin Rheumatol; 2017 Jul; 29(4):343-347. PubMed ID: 28368978 [TBL] [Abstract][Full Text] [Related]
36. Lupus mesenteric vasculitis: clinical features and associated factors for the recurrence and prognosis of disease. Yuan S; Ye Y; Chen D; Qiu Q; Zhan Z; Lian F; Li H; Liang L; Xu H; Yang X Semin Arthritis Rheum; 2014 Jun; 43(6):759-66. PubMed ID: 24332116 [TBL] [Abstract][Full Text] [Related]
37. Cryoglobulinemic vasculitis with primary Sjögren's syndrome: A case report. Hasegawa J; Hayami N; Hoshino J; Suwabe T; Sumida K; Mise K; Ueno T; Yamanouchi M; Sawa N; Ohashi K; Fujii T; Takaichi K; Ubara Y Mod Rheumatol; 2018 May; 28(3):570-574. PubMed ID: 26743943 [TBL] [Abstract][Full Text] [Related]
38. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235 [TBL] [Abstract][Full Text] [Related]
39. Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis. Saadoun D; Resche-Rigon M; Sene D; Perard L; Karras A; Cacoub P Ann Rheum Dis; 2008 Oct; 67(10):1431-6. PubMed ID: 18178690 [TBL] [Abstract][Full Text] [Related]